Business Wire
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $500 Million
📈
AI Sentiment
Highly Positive
9/10
Qiagen N.V. News
Latest updates and market news for QGEN
2 news
Dec 16 - Dec 22, 2025
Page 1
Zacks
EC Approves Label Expansion of INCY's Lymphoma Drug Minjuvi
📈
AI Sentiment
Highly Positive
9/10
Share this news page